stars 1 stars 2 stars 3

Shenzhen SiBionics Co. Ltd. is a venture-backed MedTech startup specializing in R&D and commercialization of advanced active implantable medical devices and medical imaging artificial intelligence. SiBionics has incubated four projects - Retinal Prosthesis, Continuous Glucose Monitoring, AI Diabetic Retinopathy Screening, and Gastric Cancer Screening - with more in the pipeline. 深圳硅基仿生科技有限公司是一家致力于医用有源植入和医疗人工智能研发与产业化的公司。总部位于深圳,并在美国洛杉矶、北京和广州设有分部。 硅基在研的项目包括植入式视网膜电刺激器、持续葡萄糖监测、糖网筛查和胃癌筛查,覆盖了健康管理、慢病管理、疾病筛查、疾病诊断和疾病治疗等领域。

SiBionics Questions

The SiBionics annual revenue was $45.4 million in 2026.

Alfred Hu is the Senior Vice President of SiBionics.

30 people are employed at SiBionics.

Top SiBionics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users